Unknown PHASE3 INTERVENTIONAL NCT00139165

Long-Term Treatment of Collagenous Colitis With Budesonide

Long-Term Treatment of Collagenous Colitis With Budesonide. Prospective, Doubleblind Placebo-Controlled Trial.

Sponsor: AstraZeneca

Updated 5 times since 2017 Last updated: Mar 3, 2008 Started: Sep 30, 2004 Completion: Mar 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Collagenous Colitis, this trial is ongoing. The trial is conducted by AstraZeneca and has accumulated 5 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Sep 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca
Bonderup, Ole K., M.D.

Data source: Bonderup, Ole K., M.D.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aalborg, Denmark
• Aarhus, Denmark